Exhibition · Zurich, Switzerland
Targeted Cancer Therapies World Congress 2010
Biotechnology · Inventions, Innovations · Pharmaceuticals
Key numbers
- Editions on record
- 1first in 2010
About Targeted Cancer Therapies World Congress 2010
The World’s first strategic event to address critical issues in bringing targeted therapies for cancer from early development into the market.
Key representation from Roche, Novartis, Biogen Idec, ImClone Systems, Merck Serono, Merck & Co, Abbott Laboratories, Pfizer, AstraZeneca, Human Genome Sciences, Bayer, Sanofi Aventis and many more.... Join them register now!
Taking aim - the oncology market looks to the nex generation of targeted cancer therapies . The Targeted Cancer Therapy World Congress 2010 is an executive-level, interactive conference experience tackling the biggest issues facing the oncology industry today.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2010 | 21–23 Sep 2010 | Swissôtel Zurich Zurich, Switzerland | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Targeted Cancer Therapies World Congress 2010?
The next dates haven't been confirmed. The last edition we have on record was 21–23 Sep 2010.
Where is it held?
The last edition we have was at Swissôtel Zurich, Zurich, Switzerland.